These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 30556153)
1. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group. Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM; J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852 [TBL] [Abstract][Full Text] [Related]
4. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692 [TBL] [Abstract][Full Text] [Related]
5. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy. O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178 [TBL] [Abstract][Full Text] [Related]
6. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea. Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007 [TBL] [Abstract][Full Text] [Related]
7. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT; J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429 [TBL] [Abstract][Full Text] [Related]
8. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. van Leeuwen FE; Ng AK Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498 [TBL] [Abstract][Full Text] [Related]
9. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study. Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813 [TBL] [Abstract][Full Text] [Related]
10. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078 [TBL] [Abstract][Full Text] [Related]
11. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228 [TBL] [Abstract][Full Text] [Related]
12. Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors. Abou-Antoun T; Mikhael R; Massoud M; Chahine G; Saad A Asian Pac J Cancer Prev; 2016; 17(2):749-54. PubMed ID: 26925674 [TBL] [Abstract][Full Text] [Related]
13. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554 [TBL] [Abstract][Full Text] [Related]
14. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907 [TBL] [Abstract][Full Text] [Related]
15. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years. Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768 [TBL] [Abstract][Full Text] [Related]
16. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma. Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913 [TBL] [Abstract][Full Text] [Related]
17. Secondary Malignancies Following Treatment for Hodgkin's Lymphoma in Childhood and Adolescence. Dörffel W; Riepenhausenl M; Lüders H; Brämswig J; Schellong G Dtsch Arztebl Int; 2015 May; 112(18):320-7, i. PubMed ID: 26037468 [TBL] [Abstract][Full Text] [Related]
18. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074 [TBL] [Abstract][Full Text] [Related]
19. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort. Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]